Latest News about EXAS
Recent news which mentions EXAS
Cathie Wood Is Betting Big on These 5 AI Stocks
March 01, 2023
From InvestorPlace
Canaccord Genuity Maintains Buy Rating for Exact Sciences: Here's What You Need To Know
February 22, 2023
Tickers
EXAS
From Benzinga
Exact Sciences (EXAS) Q4 2022 Earnings Call Transcript
February 21, 2023
Tickers
EXAS
From Motley Fool
After-Hours Action: What's Going On With Exact Sciences Stock?
February 21, 2023
Tickers
EXAS
From Benzinga
Cathie Wood Bulks Up On Shopify Amid Stock's 18% Post-Earnings Drop, Sells This Major Holding Up 30% This Week
February 18, 2023
From Benzinga
25 AI Stocks to Buy Right Now
February 16, 2023
From InvestorPlace
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2023
February 10, 2023
From Benzinga
3 Growth Stocks That Are Off to Hot Starts in 2023
February 08, 2023
From Motley Fool
7 AI Penny Stocks to Watch as a New Bull Market Emerges
February 07, 2023
From InvestorPlace
Could Exact Sciences Stock Help You Become a Millionaire?
February 03, 2023
Tickers
EXAS
From Motley Fool
Why Is Biophytis (BPTS) Stock Up 69% Today?
February 02, 2023
From InvestorPlace
From InvestorPlace
Cathie Wood Trims Robinhood Stake As Stock Gains 28% In January — Also Offloads Shares In This Biotech Company
January 31, 2023
From Benzinga
'I Think You Should Take The Money And Run': Cramer On This Stock Up 52% Over Past Month
January 25, 2023
From Benzinga
Better Long-Term Buy in 2023: Exact Sciences or Veracyte?
January 24, 2023
From Motley Fool
From Motley Fool
From Benzinga
48.8% of Cathie Wood's Portfolio Is in These 7 Stocks
January 23, 2023
From Motley Fool
Down 40% in 2022, Can Exact Sciences Recover in 2023?
January 23, 2023
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023
January 18, 2023
From Benzinga
Bulls And Bears Of The Week: Tesla, Apple, Microsoft And Dogecoin Millionaire's Plan To Buy More Cardano
January 14, 2023
From Benzinga
Will Investors Notice Exciting Sign On Exact Sciences's Chart?
January 12, 2023
Tickers
EXAS
From Benzinga
EXAS Nears Key Buy Signal in Active Biotech ETF ARKG
January 11, 2023
From ETF Trends
Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest's Flagship Fund, Catapulting Past Zoom, Tesla
January 11, 2023
From Benzinga
Exact Sciences Breaks Up From This Pattern, Signals Massive Reversal: Is A Bull Cycle In The Cards?
January 09, 2023
Tickers
EXAS
From Benzinga